BlackRock’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $341M | Buy |
18,994,958
+4,239,681
| +29% | +$80.2M | 0.01% | 1476 |
|
|
2026
Q1 | $321M | Buy |
14,755,277
+472,024
| +3% | +$9.14M | 0.01% | 1399 |
|
|
2025
Q4 | $307M | Buy |
14,283,253
+1,083,408
| +8% | +$22.8M | 0.01% | 1413 |
|
|
2025
Q3 | $254M | Buy |
13,199,845
+1,084,623
| +9% | +$19.3M | ﹤0.01% | 1521 |
|
|
2025
Q2 | $207M | Buy |
12,115,222
+2,208,354
| +22% | +$94.2M | ﹤0.01% | 1608 |
|
|
2025
Q1 | $632M | Sell |
9,906,868
-1,285,118
| -11% | -$135M | 0.01% | 878 |
|
|
2024
Q4 | $1.36B | Buy |
11,191,986
+168,672
| +2% | +$20.7M | 0.03% | 518 |
|
|
2024
Q3 | $1.38B | Buy |
11,023,314
+698,910
| +7% | +$96.6M | 0.03% | 505 |
|
|
2024
Q2 | $1.63B | Buy |
10,324,404
+4,364,034
| +73% | +$561M | 0.04% | 414 |
|
|
2024
Q1 | $772M | Sell |
5,960,370
-251,422
| -4% | -$30.8M | 0.02% | 745 |
|
|
2023
Q4 | $599M | Buy |
6,211,792
+178,057
| +3% | +$17.1M | 0.02% | 870 |
|
|
2023
Q3 | $731M | Buy |
6,033,735
+530,269
| +10% | +$59.9M | 0.02% | 678 |
|
|
2023
Q2 | $630M | Buy |
5,503,466
+220,771
| +4% | +$28.5M | 0.02% | 785 |
|
|
2023
Q1 | $728M | Sell |
5,282,695
-199,471
| -4% | -$25.9M | 0.02% | 678 |
|
|
2022
Q4 | $710M | Buy |
5,482,166
+144,862
| +3% | +$16.8M | 0.02% | 677 |
|
|
2022
Q3 | $590M | Sell |
5,337,304
-270,359
| -5% | -$27.3M | 0.02% | 729 |
|
|
2022
Q2 | $420M | Buy |
5,607,663
+60,704
| +1% | +$4.47M | 0.01% | 970 |
|
|
2022
Q1 | $433M | Buy |
5,546,959
+261,725
| +5% | +$20M | 0.01% | 1088 |
|
|
2021
Q4 | $476M | Buy |
5,285,234
+525,016
| +11% | +$44.9M | 0.01% | 1068 |
|
|
2021
Q3 | $440M | Sell |
4,760,218
-106,133
| -2% | -$8.18M | 0.01% | 1084 |
|
|
2021
Q2 | $378M | Sell |
4,866,351
-647,199
| -12% | -$49.1M | 0.01% | 1263 |
|
|
2021
Q1 | $411M | Buy |
5,513,550
+134,335
| +2% | +$12.4M | 0.01% | 1182 |
|
|
2020
Q4 | $917M | Sell |
5,379,215
-76,376
| -1% | -$11.3M | 0.03% | 565 |
|
|
2020
Q3 | $766M | Buy |
5,455,591
+83,856
| +2% | +$12.7M | 0.03% | 565 |
|
|
2020
Q2 | $861M | Buy |
5,371,735
+484,291
| +10% | +$65.9M | 0.03% | 476 |
|
|
2020
Q1 | $478M | Buy |
4,887,444
+247,159
| +5% | +$28.3M | 0.02% | 627 |
|
|
2019
Q4 | $599M | Buy |
4,640,285
+134,544
| +3% | +$13.6M | 0.02% | 693 |
|
|
2019
Q3 | $339M | Buy |
4,505,741
+583,198
| +15% | +$68.9M | 0.01% | 1027 |
|
|
2019
Q2 | $596M | Sell |
3,922,543
-264,721
| -6% | -$32.2M | 0.03% | 655 |
|
|
2019
Q1 | $499M | Sell |
4,187,264
-657,967
| -14% | -$84.6M | 0.02% | 733 |
|
|
2018
Q4 | $529M | Buy |
4,845,231
+36,972
| +0.8% | +$4.62M | 0.03% | 621 |
|
|
2018
Q3 | $777M | Buy |
4,808,259
+121,003
| +3% | +$16.5M | 0.03% | 519 |
|
|
2018
Q2 | $620M | Sell |
4,687,256
-1,374,153
| -23% | -$130M | 0.03% | 600 |
|
|
2018
Q1 | $449M | Sell |
6,061,409
-224,934
| -4% | -$15M | 0.02% | 772 |
|
|
2017
Q4 | $350M | Buy |
6,286,343
+58,433
| +0.9% | +$3.1M | 0.02% | 951 |
|
|
2017
Q3 | $282M | Buy |
6,227,910
+1,008,468
| +19% | +$40.3M | 0.01% | 1074 |
|
|
2017
Q2 | $176M | Sell |
5,219,442
-73,287
| -1% | -$2.39M | 0.01% | 1408 |
|
|
2017
Q1 | $157M | Buy |
5,292,729
+5,175,193
| +4,403% | +$160M | 0.01% | 1468 |
|
|
2016
Q4 | $3.22M | Buy |
117,536
+8,256
| +8% | +$332K | ﹤0.01% | 1060 |
|
|
2016
Q3 | $6.71M | Buy |
109,280
+91,084
| +501% | +$2.75M | 0.01% | 846 |
|
|
2016
Q2 | $347K | Buy |
18,196
+15,160
| +499% | +$281K | ﹤0.01% | 1824 |
|
|
2016
Q1 | $60K | Buy |
3,036
+1,673
| +123% | +$29.2K | ﹤0.01% | 2273 |
|
|
2015
Q4 | $53K | Sell |
1,363
-27,370
| -95% | -$887K | ﹤0.01% | 2018 |
|
|
2015
Q3 | $923K | Buy |
28,733
+27,649
| +2,551% | +$938K | ﹤0.01% | 1316 |
|
|
2015
Q2 | $33K | Sell |
1,084
-112
| -9% | -$2.29K | ﹤0.01% | 2164 |
|
|
2015
Q1 | $16K | Hold |
1,196
| – | – | ﹤0.01% | 2470 |
|
|
2014
Q4 | $17K | Hold |
1,196
| – | – | ﹤0.01% | 2455 |
|
|
2014
Q3 | $25K | Hold |
1,196
| – | – | ﹤0.01% | 2230 |
|
|
2014
Q2 | $36K | Sell |
1,196
-2
| -0.2% | -$63 | ﹤0.01% | 2084 |
|
|
2014
Q1 | $29K | Buy |
1,198
+64
| +6% | +$1.63K | ﹤0.01% | 2176 |
|
|
2013
Q4 | $23K | Buy |
1,134
+96
| +9% | +$2.85K | ﹤0.01% | 2298 |
|
|
2013
Q3 | $49K | Hold |
1,038
| – | – | ﹤0.01% | 1849 |
|
|
2013
Q2 | $40K | Buy |
+1,038
| New | +$37.1K | ﹤0.01% | 1954 |
|
Other funds holding SRPT
EAM
BlackRock's SRPT Position: Q2 2026 in Review
BlackRock increased its Sarepta Therapeutics (SRPT) stake by 29% in Q2 2026, buying an estimated $80.2M and bringing the position to 18,994,958 shares worth $341M. The position accounts for 0.01% of the portfolio, ranked #1476.
BlackRock first reported a position in SRPT in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.63B in Q2 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.
- BlackRock held 18,994,958 shares of Sarepta Therapeutics worth $341M as of Q2 2026.
- BlackRock bought 4,239,681 Sarepta Therapeutics shares in Q2 2026, an estimated $80.2M.
- Sarepta Therapeutics made up 0.01% of BlackRock's portfolio in Q2 2026, its #1476 holding.
- BlackRock first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 53 quarters since.
- BlackRock's Sarepta Therapeutics position peaked at $1.63B in Q2 2024.
- 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.